Global capabilities
Delivering value beyond the test result
At Mayo Clinic Laboratories, laboratory medicine is about more than a test result — it’s about everything that contributes to providing answers for your patients. We develop individualized support solutions for each client that extend through all aspects of the relationship to ensure the delivery of answers, not just results.
Specialized testing areas include:
Global logistics and shipping
We develop unique relationships with each client to individualize logistics support, which is coordinated by a local team who ensures a seamless process before the first patient specimen is sent. Our specialists collaborate with packaging suppliers to create unique solutions that extend the stability of specimens traveling around the world.
These experts ensure specimens are handled carefully and efficiently through close connections to shipping carriers. The air carriers we work with are experienced with processing clinical specimens.
Optimized, expeditious processing
We recognize many medical conditions have a window of opportunity for the best possible outcomes. Our tests and processes are optimized to better serve patients and deliver results with outcomes in mind. We do not triage specimens across a network of labs or use a batch-testing business model. Result turnaround times are expedited by:
- Running tests continuously – your samples are processed alongside those from Mayo Clinic.
- A testing approach that incorporates comprehensive panels and algorithms when appropriate.
- Utilization of Lean and Six Sigma processes.
Reliable connectivity
We offer technology solutions to help our clients connect to us, including a secure online portal with interfacing capabilities that allows you to easily order tests and receive results. Our solutions include:
- Client-friendly test ordering through MayoLINK, which is available in eight languages.
- Expansive website with links to our open- access test catalog, which is updated daily and features comprehensive clinical information, including specimen requirements; clinical and interpretative information; performance; sample test reports; setup files; and pricing.
- 30 country-specific toll-free numbers.
News and updates
The latest
Dr. Bill Morice shares how clinical diagnostics are expanding to guide treatment and enable clinicians to target therapies more precisely.
Ann Moyer, M.D., Ph.D., explains Mayo Clinic Labs’ new focused pharmacogenomics panel, a real-time, PCR-based testing approach that assesses 10 genes known for their drug-gene associations, to provide guidance on medication selection for patients across a variety of specialities.
Personalized medicine represents unprecedented potential benefits for patients. LabConnect and Mayo Clinic BioPharma Diagnostics are working together to bring world-class laboratory testing and resources to industry partners conducting clinical research and trials.
This weeks research roundup features: Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patients who are hospitalized with Covid-19.
Topic's Include: Being vaccinated for COVID-19 means protection against more than severe illness, Vaccines to Variants, and COVID-19 variants mu, delta and what to know about mutations.
Before testing at Mayo Clinic Laboratories, Barbara Domaille, Deborah Neville, Pamela Neville, and Rylie Ronnenberg thought there could be a genetic connection to the hip problems they shared. After the testing, they knew for sure.
Topic's Include: Biden announces COVID-19 vaccine mandates that will affect 100 million Americans, how organ transplantation could become easier, starting at the U of M, and managing the pandemic that never seems to end.
In this episode of Lab Medicine Rounds, Dr. Meera Sridharan, Assistant Professor of Medicine and Oncology and senior associate consultant in the Department of Hematology at Mayo Clinic, discusses the evolving field of direct oral anticoagulant (DOAC) reversals and the critical advances being made.
Mayo Clinic Laboratories has been key to Minnesota’s COVID-19 testing strategy since the start of the pandemic. At their height in 2020, Mayo’s COVID-19 labs were running 24/7, processing up to 90,000 COVID-19 specimens a day. Dr. Morice explains what Mayo Clinic Laboratories is doing now to handle the latest surge.
A web of innovation within Mayo Clinic Laboratories links research and test development with clinical practice, enabling for some of the world’s most pioneering methodologies. Underpinning this innovation network are unique supports that provide inventive and essential solutions to broaden testing capabilities.
This weeks research roundup features Consensus-Based Recommendations on the prevention of squamous cell carcinoma in solid organ transplant recipients: A delphi consensus statement.
Topic's Include: 3 things you can do to stop the spread of COVID-19 regardless of whether you’re vaccinated, and monoclonal antibody treatment combo reduces hospitalization among high-risk patients with COVID-19.
Topic's Include: Immunity to COVID-19 could last longer than you'd think, the CDC urging unvaccinated people to not travel labor day weekend, and Mayo study finds antibody treatment can help COVID-19 patients.